New Drug Strategy May Put Hormone-Driven Hypertension Into Lasting Remission

Coverage, in order

1. 4d ago
   Inside Precision Medicine indie peer-reviewed

   New Drug Strategy May Put Hormone-Driven Hypertension Into Lasting Remission

   In a small study published in the New England Journal of Medicine, researchers led by Queen Mary University of London found that prolonged treatment with an aldosterone synthase inhibitor led to sustained improvements in blood pressure and hormone levels in patients with primary aldosteronism, a…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.